Latest News

New medicine can revolutionize treatment of inflammatory diseases and cancer

A medicine is being developed at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) which controls the concentration of oxygen radicals in immune cells, and could revolutionise treatment of inflammatory diseases or even cancer.

Source link

Related posts

Janssen va étendre l’utilisation de TREMFYA®▼ (guselkumab) pour le traitement des adultes atteint d’arthrite psoriasique


STAT Plus: Relay Therapeutics raises $400 million in venture capital funding


Fresh Spanish virus outbreak sees 70,000 locked down


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World